Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2012
07/19/2012US20120184535 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
07/19/2012US20120184534 Tri-cyclic pyrazolopyridine kinase inhibitors
07/19/2012US20120184533 Small molecule inhibitors of parp activity
07/19/2012US20120184531 BENZOFURO[3,2-c] PYRIDINES AND RELATED ANALOGS AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS FOR THE TREATMENT OF OBESITY, METABOLIC SYNDROME, COGNITION AND SCHIZOPHRENIA
07/19/2012US20120184528 7-ARYL-1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
07/19/2012US20120184527 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
07/19/2012US20120184524 Pyrazolopyridine kinase inhibitors
07/19/2012US20120184520 Glycine compound
07/19/2012US20120184516 sGC Stimulators
07/19/2012US20120184514 Vitamin d compounds and methods for preparing same
07/19/2012US20120184506 Use of sulfated oligosaccharides as slimming cosmetic ingredients
07/19/2012US20120184489 Prodrugs comprising an insulin linker conjugate
07/19/2012US20120184488 Insulin analogues of enhanced receptor-binding specificity
07/19/2012US20120184487 Insulin derivatives
07/19/2012US20120184486 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
07/19/2012US20120183633 Compositions and functional foods for treating and preventing obesity using polygonum cuspidatum butanol fraction and ethyl acetate fraction
07/19/2012US20120183617 Composition and method for treatment of diabetes
07/19/2012US20120183616 Long acting insulin composition
07/19/2012US20120183610 glucocorticoid therapy
07/19/2012US20120183600 Novel composition for treating metabolic syndrome and other conditions
07/19/2012US20120183585 Gel based wound dressing and a method of synthesizing the same
07/19/2012US20120183579 Compounds for inflammation and immune-related uses
07/19/2012US20120183577 Compositions useful as inhibitors of protein kinases
07/19/2012US20120183565 Fully human antibodies to btla
07/19/2012US20120183564 Inhibition of endosomal toll-like receptor activation
07/19/2012US20120183563 Iminothiadiazine dioxide compounds as bace inhibitors, compositions and their use
07/19/2012US20120183561 Alpha-4-beta-7 heterodimer specific antagonist antibody
07/19/2012US20120183558 Antibody molecules which bind il-17a and il-17f
07/19/2012US20120183549 Chemokine receptor binding polypeptides
07/19/2012US20120183540 Methods of promoting fat loss comprising administering an alk7 inhibitor
07/19/2012US20120183537 1,2,4-thiazoloidin-3-one derivatives and their use in the treatment of cancer
07/19/2012US20120183527 Measurement of anti-amyloid antibodies in human blood
07/19/2012US20120183521 Equine nutritional supplement
07/19/2012US20120183516 Lactic acid bacteria and bifidobacteria for treating endotoxemia
07/19/2012US20120183513 Lactobacillus Supplement for Alleviating Type I Diabetes
07/19/2012US20120183504 Composition and use of probiotic strain gm-263 (adr-1) in treating renal fibrosis in diabetes
07/19/2012US20120183502 Combination therapy for lysosomal storage diseases
07/19/2012CA2824380A1 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
07/18/2012EP2476680A1 (1-Azinone)-Substituted Pyridoindoles
07/18/2012EP2476426A1 Treatment and prevention of symptoms of metabolic syndrome
07/18/2012EP2476422A1 Pharmaceutical compositon for anti-thrombotic diseases, its preparation method and use
07/18/2012EP2476418A1 Pharmaceutical compound and composition for use in treating type II diabetes comprising rosiglitazone in a specific particle size
07/18/2012EP2476415A2 Treating bone-related disorders with selective androgen receptor modulators
07/18/2012EP2475658A1 2 -aminodihydro [1, 3]thiazines as bace 2 inhibitors for the treatment of diabetes
07/18/2012EP2475645A1 5- (3, 4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as hdl cholesterol raising agents
07/18/2012EP2475644A1 Hsl inhibitors useful in the treatment of diabetes
07/18/2012EP2475397A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes
07/18/2012EP2475376A2 Formulations for lysosomal enzymes
07/18/2012EP2283022B1 Furo [3, 2-b]pyrr0l-3-0nes as cathepsin s inhibitors
07/18/2012EP2121600B1 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
07/18/2012EP2120923B1 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
07/18/2012EP2024340B1 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
07/18/2012EP1999132B1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
07/18/2012EP1829542B1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same
07/18/2012CN1951917B Pyridinone derivatives for treatment of atherosclerosis
07/18/2012CN1935260B Human antibodies that bind human tnfalpha
07/18/2012CN1753886B Process for producing acid adduct salt of polyacidic base compound
07/18/2012CN1443167B Azacyclic compounds for use in treatment of 5-serotonin related diseases
07/18/2012CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta
07/18/2012CN102596961A Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors
07/18/2012CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
07/18/2012CN102596941A Compounds for the treatment of dyslipidemia and related diseases
07/18/2012CN102596212A Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders
07/18/2012CN102596211A Compositions and functional foods for treating and preventing obesity using polygonum cuspidatum butanol fraction and ethyl acetate fraction
07/18/2012CN102596208A Composition to induce specific immune tolerance
07/18/2012CN102596191A Pharmaceutical compositions comprising bi-1356 and metformin
07/18/2012CN102586237A Poly-nucleic acid molecule and application thereof
07/18/2012CN102586129A Oil producing rhodococcus sp.RHA-MLDS having MLDS (Multiple Low Dose Streptozotocin) gene knocked out and purpose of oil producing rhodococcus sp.RHA-MLDS
07/18/2012CN102586119A Functional monascus strain, and preparation method and application of functional highland barley monascus prepared by using functional monascus strain
07/18/2012CN102585029A Preparation method and application of physiologically active notoginseng polysaccharide
07/18/2012CN102585015A Fusion protein containing glicetin-1 as well as preparation method and application
07/18/2012CN102584997A Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
07/18/2012CN102584976A Human serum amyloid A1 and preparation method and application thereof
07/18/2012CN102584830A Dihydroindene amide compounds, and medicinal composition and application thereof
07/18/2012CN102584799A Aromatic nitrogenous six-membered ring compounds
07/18/2012CN102584756A Novel monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones
07/18/2012CN102584754A Fused aromatic compounds having anti-diabetic activity
07/18/2012CN102584741A Amides compound, method for preparing same, composition and application thereof
07/18/2012CN102584687A Ethylene derivatives used as selective estrogen receptor modulators
07/18/2012CN102584685A Aryl compounds as PPAR ligands and their use
07/18/2012CN102580232A Silk fibroin micro-needle system, silk fibroin nanometer particle and preparation method thereof
07/18/2012CN102580110A Fat-soluble material having coating structure
07/18/2012CN102580108A Novel oily liquid auxiliary material for soft capsules for reducing blood fat
07/18/2012CN102580092A Regulation of ferroportin and application thereof
07/18/2012CN102580087A In-situ adipocyte composite inhibitor for local weight loss and body care of human bodies and preparation method thereof
07/18/2012CN102580067A Combination therapy for treating protein deficiency disorders
07/18/2012CN102580061A Intranasal insulin preparation and preparation method thereof
07/18/2012CN102580060A Medicine composition for curing diabetes mellitus and complications of diabetes mellitus
07/18/2012CN102580048A Chinese medicine for losing weight and preparation method thereof
07/18/2012CN102580045A Application of intestine-consolidating capsules to preparation of medicines for reducing blood viscosity and inhibiting thrombopoiesis
07/18/2012CN102580030A External traditional Chinese medicine composition having effect of reducing blood sugar, preparation prepared from the external traditional Chinese medicine composition, and their preparation method
07/18/2012CN102580024A Composition for treating cardiovascular diseases
07/18/2012CN102580006A Weight-losing and health-casing tea and preparation method thereof
07/18/2012CN102579956A Medicament composition and application thereof
07/18/2012CN102579915A Medicine for treating wound non-healing of diabetics and preparation method thereof
07/18/2012CN102579904A Chinese medicinal composition and preparation method and application thereof
07/18/2012CN102579882A Dropping pills for preventing and curing hypertension and hyperlipidemia and preparation method
07/18/2012CN102579872A Medical composition with weight reducing function
07/18/2012CN102579856A Preparation method of weight-reducing bathing powder
07/18/2012CN102579839A Pharmaceutical preparation for treating diabetes and preparation method of same
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 1298